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OVERVIEW OF CANCERS
This paper reviews the four cancer sites: brain, bone, sarcoma and
thyroid, which do not fit readily into the organ-specific groups
defined for the other papers in this supplement. Ionising radiation
is a cause of cancers of both the bone and thyroid, and thus this
exposure will be considered together in the relevant section.
Brain and central nervous system (CNS) cancers
Primary brain and CNS cancers are rare. Over the past 10 years in
Britain, brain cancers have accounted for about 1.8% of male and
1.4% of female cancers, being 20–50% more common in men than
women. Other cancers of the CNS have accounted for an additional
0.3% of all male and female cancers. The most common types
of primary brain tumours are gliomas, meningiomas and astro-
cytomas (Kleihues and Cavanee, 2000).
Age-specific incidence and mortality rates in both sexes have
shown upward trends in all age groups (Preston-Martin et al, 2006)
since the 1970s and the 1950s, respectively (Quinn et al, 2005).
There have been few positive findings in searching for environ-
mental causal factors for brain cancer, probably because they
comprise a heterogeneous group of cancers with different
aetiologies. The nature and magnitude of the risk factors for
primary brain tumours are not clear (Wrensch et al, 2002), and the
definition and classification of these tumours often differ between
studies. Retrospective assessment of exposure along with unde-
fined latency periods for induction of these cancers has led to
imprecise risk estimates. Despite these limitations, exposure to
inorganic lead, non-arsenical insecticides and work in petroleum
refining have been identified as relevant occupational risk factors
for brain cancer.
Survival from brain cancer is low; 1-year relative survival for
patients diagnosed during 1996–1999 was reported as 30.4% in
men and 28.8% in women, and has shown little change over the
years (Rachet et al, 2008). Five-year survival was reported as 11.6%
in men and 14% in women, with that for men showing a significant
improvement since 1986–1990.
Bone cancer
Cancers that arise in the bone or articular cartilage account for
B0.5% of all malignant neoplasms in humans (Miller et al, 2006).
In Britain, over recent years, the number of cancers registered has
been relatively stable, whereas the number of people who died
from the condition steadily increased between 1995 and 2004.
There are three main types of bone cancer: osteosarcoma (the most
common), chondrosarcoma and Ewing’s sarcoma. Osteosarcoma
peaks in adolescence (around 17 years) and later in life (around 80
years), whereas chondrosarcoma is rare in childhood and rates rise
with advancing age (peaking between 70 and 80 years of age).
Ewing’s sarcoma has a similar age distribution to osteosarcoma for
early years, but the condition is rare over 35 years of age.
Survival rates have improved over the past 35 years, being
consistently higher in females (Cancer Research UK, 2007a), and
cancer treatment is usually successful (two out of three people
cured) if the disease has not spread to other parts of the body.
Five-year survival rates generally vary between 10% and 90%
depending on the type, grade and stage of disease, as well as age at
diagnosis. The main exposure that induces bone cancer is ionising
radiation, with the exception of Ewing’s sarcoma (Miller et al,
2006). Occupational exposure to radium has been associated with
osteosarcoma, and osteosarcoma and chondrosarcoma have both
been linked with exposure to plutonium. Other non-occupational
risk factors for bone cancer include high-dose therapeutic
radiation, predisposing genetic factors and Paget’s disease.
Soft-tissue sarcoma (STS)
Soft-tissue sarcoma arises in fibrous tissue, fat, muscle, blood and
lymph vessels and cartilage, each with potentially distinct
aetiologies (Berwick, 2006; Toro et al, 2006). In GB, there are
B1200 new cases diagnosed and 660 STS-related deaths each year
(Swerdlow et al, 2001). In addition, about 90 men and women are
diagnosed with Kaposi’s sarcoma, of which there are about eight
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incidence of STS among adults (with the exception of an
unchanged rate in young women), which may largely be because
of changes in reporting and coding (Swerdlow et al, 2001). For
STS, overall the 5-year survival rate is between 50 and 60% (Storm
and Hat, 1998), with a wide variation depending on anatomical site
and tumour histology (Weitz et al, 2003; Mendenhall et al, 2005).
The aetiology of STS is difficult to study because of the relatively
low incidence and inherent misclassification of histology (Berwick,
2006), with the different histological subtypes often grouped together
masking more in-depth analysis. Occupational risk factors may not
be uniform across these subtypes (Hoppin et al, 1999).
Thyroid cancer
This cancer is relatively uncommon but is the most common
malignancy of the endocrine system (Ron and Schneider, 2006)
and is more common in women (2.1% of cancers in women) than
in men (0.7% of cancers in men) (Parkin et al, 2001). In Britain,
the numbers of registered cancers have steadily increased,
although the number of deaths has been steady over recent years.
There are four main types of thyroid cancer: papillary, follicular,
anaplastic and medullary, these being either well differentiated
(papillary, follicular and medullar) or poorly differentiated (i.e.,
anaplastic). Papillary thyroid cancer is the most common,
accounting for about 60% of diagnosed cases (Cancer Research
UK, 2007b). Thyroid cancer survival rates have improved over the
past 35 years, with rates being consistently higher in women.
Survival rates generally depend on tumour histology, stage and age
at diagnosis. Anaplastic thyroid cancer has the lowest (10–20%)
5-year survival rates, and papillary thyroid cancer has the best
5-year survival rate (B100%) if diagnosed early.
Radiation is one of the main risk factors clearly associated with
thyroid cancer (Ron and Schneider, 2006), and these risks are parti-
cularly evident in those exposed during childhood. Well-differentiated
papillary cancer is the principal cell type induced by radiation, but an
increase in follicular and anaplastic carcinomas may occur as the
population ages. Other non-occupational risk factors for thyroid
cancer include a history of benign thyroid diseases, a family history
of thyroid cancer and dietary factors, especially iodine deficiency.
METHODS
Occupational risk factors
Group 1 and 2A human carcinogens The agents that the International
Agency for Research on Cancer (IARC) has classified as either definite
(Group 1) or probable (Group 2A) human carcinogens for brain, bone,
STS and thyroid cancer are summarised in Table 1.
Table 1 Occupational agents, groups of agents, mixtures and exposure circumstances classified by the IARC monographs, vols 1–77 (IARC,
1972–2001), into Groups 1 and 2A, which target the brain, bone, soft-tissue sarcoma or thyroid and for which burden has been estimated
Agents, mixture,
circumstance
Main industry, use Evidence of
carcinogenicity
in human
Source of data for
estimation of numbers
ever exposed over
REP
Comments
Group 1: Carcinogenic to humans
Agents, groups of agents
Ionising radiation Radiologists, technologists, nuclear workers,
radium-dial painters, underground miners,
plutonium workers, cleanup workers
following nuclear accidents and aircraft
crew
Bone sufficient
Thyroid sufficient
CIDI
LFS (male travel and
flight attendants)
British Airways Stewards &
Stewardesses Union
(1956–1995)
2,3,7,8-tetrachlorodibenzo-
para-dioxin (TCDD)
Production; use of chlorophenols and chloro-
phenoxy herbicides; waste incineration; PCB
production; pulp and paper bleaching
STS sufficient LFS
Group 2A: Probably carcinogenic to humans
Agents, groups of agents
Non-arsenical insecticides Production; pest control and agricultural
workers; flour and grain mill workers
Brain limited LFS
Epichlorohydrin Production and use of resins, glycerine and
propylene-based rubbers; used as a solvent
Brain inadequate CAREX
Inorganic lead Lead battery industry, demolition industry,
scrap industry, smelting, refining, alloying
and casting, glass making
Brain limited CAREX Industry sectors categorised as highly
exposed were: metal ore mining,
manufacture of industrial and other
chemical products, iron and steel
basic industries, non-ferrous metal
basic industries, manufacture of
electrical machinery, apparatus,
appliances and construction
Exposure circumstances
Petroleum refining PAHs Brain UK Petroleum Industry Records
Abbreviations: CAREX¼CARcinogen EXposure Database; CIDI¼Central Index of Dose Information; CoE¼Census of Employment; LFS¼Labour Force Survey; REP¼risk
exposure period.
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Detailed reviews of occupational risk factor studies identified for
cancers of the brain, bone and thyroid, as well as STS, are provided
in the relevant Health and Safety Executive (HSE) technical reports
(Health and Safety Executive (HSE), 2012a,b,c).
Occupational exposures considered for brain cancer
The exposures/occupational circumstances that have been classi-
fied as Group 1/2A, where there is strong or suggestive evidence
for brain cancer carcinogenicity, are as follows: non-arsenical
insecticides, epichlorohydrin, inorganic lead and petroleum
refining (Siemiatycki et al, 2004). Other exposures that have been
proposed as relevant agents but which were not considered here
because of insufficient evidence include vinyl chloride, formalde-
hyde, radiation and electromagnetic fields (mobile phones), and
work in the rubber industry, fire-fighting and laboratory scientists
(Wrensch et al, 2002; Preston-Martin et al, 2006).
Risk estimates for occupational exposure to non-arsenical insecti-
cides and brain cancer A large number of occupational studies
have examined cancer risk among workers exposed to non-
arsenical insecticides (or pesticides in general), but no studies of
UK workers have been published. For the present study, the risk
estimate obtained from a meta-analysis of 28 studies of farmers
(published through 1994) was selected (for risk to farmers and
other workers), and this reported a summary relative risk (RR) of
1.06 (95% confidence interval (CI)¼0.99–1.14) (Acquavella et al,
1998). This risk estimate was also consistent with a previous
analysis (Blair et al, 1992). The Acquavella et al (1998) estimate
was chosen in preference to another meta-analysis that also
investigated the association between farming and pesticide
exposure and the risk of brain cancer using studies published
between 1981 and 1996 (Khuder et al, 1998). This obtained a
summary RR of 1.30 (95% CI¼1.09–1.56), which the authors
suggested as evidence for a weak association with pesticide
exposure. However, in this meta-analysis, four studies were
included in which the risk estimates were greater than three, and
one of these studies was from China where exposure circumstances
are different from those in GB.
The result of a further meta-analysis of crop protection
product manufacturing workers by Jones et al (2009), which
included studies from around the world, was used for workers
employed in pesticide manufacturing (meta-RR¼1.01, 95%
CI¼0.75–1.36). A review of cohort and case–control studies
published before 1995 found equivocal results for risk of brain
tumours and exposure to pesticides (Bohnen and Kurland, 1995).
In another large US Agricultural Health Study that investigated
licensed pesticide applicators, no increase in brain cancer
incidence (Alavanja et al, 2005) or mortality was observed (Blair
et al, 2005).
Epichlorohydrin Epichlorohydrin has been used in the produc-
tion of epoxy resins, synthetic glycerine and elastomers (NCI,
1985), is used to cure propylene-based rubbers, as a solvent for
cellulose esters and ethers, and in resins for the paper industry
(International Agency for Research on Cancer (IARC), 1999).
Risk estimates for occupational exposure to epichlorohydrin and
brain cancer A small nested case–control study of 11 cases
observed that routine potential exposure to epichlorohydrin was
associated with CNS tumours, but with a large CI (odds ratio¼4.2,
95% CI¼0.7–26.0) (Barbone et al, 1994). Other cohort studies of
epichlorohydrin-exposed workers (mostly carried out in the
United States) suggest that the number of people exposed has
been small (Enterline et al, 1990; Tsai et al, 1990, 1996), with only
a few deaths from brain cancer/CNS resulting in standardised
mortality ratios (SMR) o1.0. As the number of workers exposed
to high concentrations of epichlorohydrin was very small, no
attributable fraction (AF) was calculated in the current study for
exposure to epichlorohydrin.
Inorganic lead In 2004, the IARC reassessed the evidence on the
carcinogenicity of lead and reclassified inorganic lead as a
probable carcinogen (Group 2A) based on additional limited
evidence in humans (International Agency for Research on Cancer
(IARC), 2006). Occupational exposure occurs in mining, smelting
and refining, storage battery manufacture, welding and steel
cutting, as well as printing. High exposure occurs in smelting and
refining of the metal, as well as in battery plants (Fu and Boffetta,
1995). Moderate exposure has occurred among welders of metals
containing lead, or painted with lead, lead glass workers, lead
miners, workers repairing car radiators, printers using lead type
and production workers using lead (e.g., producing lead chromate
paint). However, it has been noted that exposures have decreased
markedly since the 1950s in industrialised countries (Steenland
and Boffetta, 2000), and epidemiological studies have mainly
concentrated on highly exposed workers in these occupations
historically exposed.
Risk estimates for occupational exposure to inorganic lead and
brain cancer For the present study, the summary RR of 1.06 (95%
CI¼0.80–1 40) was taken from the meta-analysis of Steenland and
Boffetta (2000) for ‘high’-exposure industries and used in the AF
calculation. This study included battery and smelter workers and
workers monitored for lead exposure from the United States, Italy,
Sweden and Finland, although only a small number of cancer cases
were observed (n¼69). Fu and Boffetta (1995) reviewed 16 cohort
studies and 13 case–control studies (nested and population based)
relating to lead exposure and cancer risk, but no meta-analysis was
performed for brain/CNS cancers.
Risk estimates for employment in petroleum refining and brain
cancer All of the studies of petroleum refining industry
workers are relatively extensive, and the exposure circumstances
of each cohort in the various countries would be expected to be
similar because the refining process is relatively standard. For the
present study, an SMR of 1.02 (95% CI¼0.83–1.25) was obtained
from a recent update study by Sorahan (2007). This study
had followed up mortality (1951–2003) and cancer incidence
(1971–2003) in a large number of UK workers (28,555 refinery
workers and 16,477 distribution workers) over the exposure period
of interest.
Wong and Raabe (2000) conducted a meta-analysis of
combined data from studies in the United States, Canada,
Australia, Finland, Sweden, Italy and United Kingdom, resulting
in a combined database of 4350000 workers. For brain cancer,
individual study SMRs ranged from 0.34 to 2.14, and the overall
meta-SMR was 1.01 (95% CI¼0.93–1.09). The review indicated
that the risk for US studies was 1.04 compared with 0.97 for
non-US studies.
Occupational exposures common to bone and thyroid
cancer
Ionising radiation Key occupational groups exposed to ionising
radiation include nuclear industry workers, disaster clean-up
workers, radiologists, technologists and military personnel (typi-
cally through weapon production and testing). Airline cockpit
crews also are occupationally exposed to ionising radiation of
cosmic origin. Occupational exposure via inhalation or ingestion
occurs in many situations, including underground mining, work-
ing with plutonium, reactor fuel manufacture and radium-dial
painting (luminising industry).
Brain, bone, soft tissue sarcoma and thyroid
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bone and thyroid cancer By using models for workers exposed to
ionising radiation from the United Nations Scientific Committee
on the Effects of Atomic Radiation (UNSCEAR 2006) (UNSCEAR,
2008), RR estimates of 1.03 for bone cancer and 1.09 for thyroid
cancer, for both men and women, were obtained (the same
estimate is used for aircrew) on the basis of an estimated average
lifetime dose of 15.3mSv.
United Kingdom studies of radiation exposure in various
jobs show that not all radiation workers are at increased risk for
bone cancer, with radiation work registry studies consistently
reporting reduced risks for bone cancer and an increased risk for
thyroid cancer (with and without a 10-year latency period)
(Kendall et al, 1992; Muirhead et al, 1999). In contrast, studies
conducted on nuclear industry workforces show an elevated risk
for both bone and thyroid cancer (Carpenter et al, 1998; Omar
et al, 1999).
For example, Muirhead et al (1999) undertook a cohort study
on 124,743 radiation workers in the United Kingdom with a
follow-up through 1992. Two types of analyses were carried out
on this cohort. The first was an external analysis producing
SMRs and using the general population of England and Wales
for reference. The second was an internal analysis to investigate
dose–response relationships. Standardised mortality ratios were
adjusted for age, calendar year and sex, and then were reported
using an unlagged and a lagged analysis (based on a 10-year
latency period). An SMR of 0.75 (95% CI¼0.36–1.38, n¼10)
was obtained for mortality from bone cancer in the unlagged
analysis and an SMR of 0.52 (95% CI¼0.14–1.34, n¼4) for the
lagged analysis. However, risk for thyroid cancer was elevated
in both the unlagged (SMR¼1.52, 95% CI¼0.79–2.66, n¼12)
and lagged (SMR¼1.80, 95% CI¼0.90–3.21, n¼11) analyses.
The internal analysis provided a nonsignificant negative dose
trend for bone cancer (P¼0.28) from 4 deaths, and a non-
significant positive trend associated with thyroid cancer (P¼0.31)
from 11 deaths.
In another study, follow-up was conducted from 1946 to 1988
for mortality from bone and thyroid cancer in 75,006 employees of
three United Kingdom Nuclear Industry Workforces (Carpenter
et al, 1998). Data on external radiation dose were obtained for
n¼40761 workers, and individuals not monitored for exposure
to any radionuclide were used as reference in the analysis.
Four deaths from bone cancer were observed in the reference
group (SMR¼0.83), but for those monitored for radionuclide
exposure elevated SMRs of 1.81 (n¼1), 1.00 (n¼2) and 1.42
(n¼2) were observed for tritium, plutonium and others sources,
respectively. Rate ratios were elevated but not significantly
(tritium: RR¼1.31, 95% CI¼0.05–14.71, plutonium: RR¼1.01,
95% CI¼0.12–7.35 and other: RR¼2.07, 95% CI¼0.21–18.61).
In this study, there were no thyroid deaths among the tritium and
other radionuclide subgroups, and only one observed death in the
plutonium subgroup (SMR¼0.85). A significantly elevated SMR of
2.69 (n¼7, Po0.05) for thyroid cancer was observed in the
reference group, resulting in a significantly lowered rate ratio
(RR¼0.15, 95% CI¼0.01–0.89) for the group monitored for
plutonium.
Occupational exposures considered for soft-tissue sarcoma
TCDD Dioxins or chlorinated dibenzo-para-dioxins are
structurally similar to chlorinated hydrocarbons (the most
toxic form being dioxins) and are by-products of industrial
processes (e.g., coke production, manufacture of non-ferrous
metals, lime) (Eduljee and Dyke, 1996) and combustion (e.g.,
burning biomass, coal, oil), and may be released at metal
and waste recycling sites (Sweetman et al, 2004). For TCDD, the
following risk estimates were used for specific occupational
groups.
Agriculture/horticulture workers: A summary risk estimate SMR
of 1.03 (95% CI¼0.90–1.17) was obtained from a meta-analysis by
Acquavella et al (1998) to calculate the AF for horticultural,
agriculture/fishing, pest control workers, as well as for similar
occupations.
Manufacture of pesticides: An overall risk estimate from a meta-
analysis by Jones et al (2009) (SMR¼1.13, 95% CI¼0.75–1.70)
was used because the number of workers specifically involved in
the manufacture of phenoxy herbicide pesticides in GB could not
be identified.
Pulp manufacture: The risk estimate (SMR¼1.13, 95%
CI¼0.59–1.98) was chosen from an international collaborative
study (McLean et al, 2006), which included a study from Scotland
(Coggon et al, 1997).
Other industries: For industries in which levels of exposure were
not monitored, a risk estimate of 2.03 (95% CI¼0.75–4.43) was
taken from the IARC register of workers exposed to phenoxy-acid
herbicides and chlorophenols contaminated with dioxins (espe-
cially TCDD) and furans (Kogevinas et al, 1997). This study
included 21,000 workers and found six deaths from STS among
exposed workers.
Estimation of numbers ever exposed
The data sources, major industry sectors and jobs for estimation of
numbers ever exposed over the risk exposure period (REP),
defined as the period during which exposure occurred that was
relevant to the development of the cancer in the target year 2005,
are given in Table 1. The occupations with likely exposure to non-
arsenical insecticides are linked with agriculture and horticulture,
gardening, forestry, pest control, as well as with the manufacture
of these products. The Labour Force Survey gives a number of
job titles that fit these occupations, giving an estimated total of
25,563 workers (20,792 men and 4771 women) involved in their
use and 4153 workers (2835 men and 1318 women) involved in
their production. For inorganic lead exposure, the CArcinogen
EXposure database, CAREX, estimated that a total of 249,412
workers were exposed in the period 1990–1993 in a variety of
industries (Kauppinen et al, 1998). According to HSE statistics, in
the same period just o27,000 individuals were under surveillance
for lead exposure (in workplaces where exposure was at least 50%
of the Occupational Exposure Limit (OEL) or workers who had a
blood lead level above the action limit); by 2006/2007 this had
decreased by almost 70%.
Data from the LFS and Census of Employment (CoE) provided
conflicting figures of the number of people employed in the petroleum
industry. A study by Sorahan (2007) estimated that 28,555 refinery
workers were first employed between 1946 and 1974; however, not all
UK refineries were included in this study. The petroleum industry was
therefore contacted to obtain numbers of the workers employed in
petroleum refining in 1981, the year for which a point estimate was
required; numbers were estimated as 36,500 (32,602 men and 3898
women, assuming a similar split as indicated by CoE data in same
year). These figures were used to calculate the AF.
RESULTS
Owing to assumptions made about cancer latency and working age
range, only cancers in ages 25 years and above in 2005/2004 could
be attributable to occupation. In the present study, a latency period
of at least 10 years and up to 50 years has been assumed for bone,
brain and thyroid cancers; a latency period of between 0 and 20
years has been assumed for STS. Attributable fractions have been
calculated as follows: brain cancer – ionising radiation, non-
arsenical pesticides, inorganic lead, petroleum refining; bone and
thyroid cancer – ionising radiation; STS – TCDD. Table 2 provides
a summary of the attributable deaths and registrations in GB for
Occupational cancer in Britain
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women, respectively.
For all exposure scenarios combined, the overall estimated AF
fraction for brain cancer was 0.35% (95% CI¼0.03–0.72%), giving
in total (male and female) 11 (95% CI¼1–23) attributable deaths
and 14 (95% CI¼1–28) attributable registrations. On the basis of
the UNSCEAR methodology for exposure to ionising radiation, the
overall estimated AF for bone cancer was 0.02%, and for thyroid
cancer the AF was 0.05%. These estimates of risk resulted in no
attributable deaths or registrations for bone cancer, and only one
estimated thyroid cancer registration attributable to occupational
exposure. For STS, the overall AF was 2.27% (95% CI¼0.00–
7.73%), giving in total 13 (95% CI¼0–45) attributable deaths and
27 (95% CI¼ 0–90) attributable registrations.
Exposures affecting brain cancer
For non-arsenical insecticides, a total of 1,444,111 men and
288,832 women were estimated as ‘ever’ exposed during the
REP. The overall estimated total AF (for men and women) was
0.29% (95% CI¼0.08–0.51%), which resulted in 9 (95% CI¼
2–17) attributable deaths and 11 (95% CI¼3–20) attributable
registrations.
An estimated 809,058 men and 413,029 women were ‘ever
exposed’ during the REP to inorganic lead. The overall estimated
total AF (for men and women) was 0.05% (95% CI¼0.00–0.34%),
with two (95% CI¼0–11) attributable deaths and two (95%
CI¼0–13) attributable registrations.
For work in the petroleum industry, there were an estimated
117,481 men and 22,434 women ‘ever employed’ during the REP.
The overall estimated total AF (for men and women) was 0.01%
(95% CI¼0.00–0.10%), which resulted in no attributable deaths
or registrations.
Exposures affecting soft-tissue sarcoma
An estimated 838,863 men and 272,873 women were assessed
as ‘ever exposed’ to TCDD during the REP. For STS, the total
AF from exposure to TCDD was 2.27% (95% CI¼0.00–7.73%),
with 13 (95% CI¼0–45) attributable deaths and 27 (95% CI¼
0–90) attributable registrations. Men involved in the iron and steel
industry had the largest number of attributable registrations and
deaths (seven and three, respectively, for STS).
DISCUSSION
Owing to the rarity of bone cancer, all the studies reviewed
reported relatively small number (typically fewer than six cases) of
attributable cancer deaths or registrations, and this limits the
reliability of the estimates obtained. Although studies in the United
States and China have suggested that occupational exposure to
ionising radiation increases the risk for both bone and thyroid
cancer, this has not been observed in large cohort studies in the
United Kingdom, which reported no risk for bone cancer and only
an elevated risk for thyroid cancer. In addition, radiation has been
shown to be associated with STS in radium-dial painters, although
this occupation has ceased to exist since many decades (Polednak
et al, 1978).
The total AF for brain cancer for men and women of 0.35 is
significantly lower than the estimates obtained by Nurminen
and Karjalainen (2001) of 10.6 and 1.3 for men and women,
respectively, and also lower than the 2000 worldwide estimate
given by Parkin et al (2001) of 2.1% of deaths and 1.8% of
registrations. Nurminen and Karjalainen (2001) also estimated
that 0.6% of bone cancers were due to occupational expo-
sures compared with the 0.02% estimate obtained in this study.
These authors did not provide an estimate for thyroid cancer. In
contrast, Parkin et al (2001) estimated that 0.4% of thyroid cancer
deaths and 1.2% of registrations were due to occupational
exposures, which is comparable to the 0.05% reported in this
study.
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Table 2 Cancer burden estimation results for brain, bone, soft-tissue sarcoma and thyroid cancers
Agent Number
of men
ever
exposed
Number
of women
ever
exposed
Proportion
of men
ever
exposed
Proportion
of women
ever
exposed
AF men
(95% CI)
AF women
(95% CI)
Attributable
deaths
(men)
(95% CI)
Attributable
deaths
(women)
(95% CI)
Attributable
registrations
(men)
(95% CI)
Attributable
registrations
(women)
(95% CI)
Brain cancer
Inorganic lead 809,058 413,029 0.0417 0.0197 0.0007
(0.0000–0.0049)
0.0002
(0.0000–0.0012)
1
(0–9)
0
(0–2)
2
(0–11)
0
(0–2)
Non-arsenical
insecticides
1,444,111 288,832 0.0744 0.0138 0.0044
(0.0012–0.0077)
0.0008
(0.0002–0.0014)
8
(2–15)
1
(0–2)
10
(3–18)
1
(0–2)
Petroleum
refining
117,471 22,434 0.0061 0.0011 0.0001
(0.0000–0.0015)
0.0000
(0.0000–0.0003)
0
(0–3)
00
(0–3)
0
Totalsa 0.0052
(0.0006–0.0012)
0.0010
(0.0000–0.0023)
10
(1–20)
1
(0–3)
12
(1–25)
2
(0–4)
Bone cancer
Ionising radiation 252,035 39,420 0.0130 0.0019 0.0004 0.0001 0 0 0 0
Soft-tissue sarcoma
TCDD 2,084,061 649,435 0.0906 0.0281 0.0338
(0.0000–0.1137)
0.0106
(0.0000–0.0376)
11
(0–36)
3
(0–9)
22
(0–75)
4
(0–15)
Thyroid cancer
Ionising radiation 252,035 39,420 0.0130 0.0019 0.0012 0.0002 0 0 0 0
Abbreviations: AF¼attributable fraction; CI¼confidence interval; TCDD¼2,3,7,8-tetrachlorodibenzo-para-dioxin.
aTotals are the product sums and are not therefore equal to
the sums of the separate estimates of AF, deaths and registrations for each agent. The difference is especially notable where the constituent AFs are large.
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